201 related articles for article (PubMed ID: 26190113)
1. CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation.
Roccaro AM; Mishima Y; Sacco A; Moschetta M; Tai YT; Shi J; Zhang Y; Reagan MR; Huynh D; Kawano Y; Sahin I; Chiarini M; Manier S; Cea M; Aljawai Y; Glavey S; Morgan E; Pan C; Michor F; Cardarelli P; Kuhne M; Ghobrial IM
Cell Rep; 2015 Jul; 12(4):622-35. PubMed ID: 26190113
[TBL] [Abstract][Full Text] [Related]
2. Osteotropism of neuroendocrine tumors: role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro.
Cives M; Quaresmini D; Rizzo FM; Felici C; D'Oronzo S; Simone V; Silvestris F
Oncotarget; 2017 Apr; 8(14):22534-22549. PubMed ID: 28186979
[TBL] [Abstract][Full Text] [Related]
3. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
[TBL] [Abstract][Full Text] [Related]
4. Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells.
Bertran E; Crosas-Molist E; Sancho P; Caja L; Lopez-Luque J; Navarro E; Egea G; Lastra R; Serrano T; Ramos E; Fabregat I
Hepatology; 2013 Dec; 58(6):2032-44. PubMed ID: 23813475
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features.
Azab AK; Hu J; Quang P; Azab F; Pitsillides C; Awwad R; Thompson B; Maiso P; Sun JD; Hart CP; Roccaro AM; Sacco A; Ngo HT; Lin CP; Kung AL; Carrasco RD; Vanderkerken K; Ghobrial IM
Blood; 2012 Jun; 119(24):5782-94. PubMed ID: 22394600
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
[TBL] [Abstract][Full Text] [Related]
7. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
8. The effect of CXCR4 silencing on epithelial-mesenchymal transition related genes in glioma U87 cells.
Zhu Y; Yang P; Wang Q; Hu J; Xue J; Li G; Zhang G; Li X; Li W; Zhou C; Zhao M; Wang D
Anat Rec (Hoboken); 2013 Dec; 296(12):1850-6. PubMed ID: 24150861
[TBL] [Abstract][Full Text] [Related]
9. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.
Fontanella R; Pelagalli A; Nardelli A; D'Alterio C; Ieranò C; Cerchia L; Lucarelli E; Scala S; Zannetti A
Cancer Lett; 2016 Jan; 370(1):100-7. PubMed ID: 26517945
[TBL] [Abstract][Full Text] [Related]
10. Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.
Bertolini G; D'Amico L; Moro M; Landoni E; Perego P; Miceli R; Gatti L; Andriani F; Wong D; Caserini R; Tortoreto M; Milione M; Ferracini R; Mariani L; Pastorino U; Roato I; Sozzi G; Roz L
Cancer Res; 2015 Sep; 75(17):3636-49. PubMed ID: 26141860
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.
Ma N; Pang H; Shen W; Zhang F; Cui Z; Wang J; Wang J; Liu L; Zhang H
Int J Mol Med; 2015 Feb; 35(2):425-32. PubMed ID: 25504108
[TBL] [Abstract][Full Text] [Related]
12. CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway.
Wu D; Guo X; Su J; Chen R; Berenzon D; Guthold M; Bonin K; Zhao W; Zhou X
Biochim Biophys Acta; 2015 Feb; 1853(2):338-47. PubMed ID: 25450979
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue.
Albert S; Hourseau M; Halimi C; Serova M; Descatoire V; Barry B; Couvelard A; Riveiro ME; Tijeras-Raballand A; de Gramont A; Raymond E; Faivre S
Oral Oncol; 2012 Dec; 48(12):1263-71. PubMed ID: 22776129
[TBL] [Abstract][Full Text] [Related]
14. Curcumin inhibits tumor epithelial‑mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells.
Zhang Z; Chen H; Xu C; Song L; Huang L; Lai Y; Wang Y; Chen H; Gu D; Ren L; Yao Q
Oncol Rep; 2016 May; 35(5):2615-23. PubMed ID: 26985708
[TBL] [Abstract][Full Text] [Related]
15. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
[TBL] [Abstract][Full Text] [Related]
16. BMS-936564/MDX-1338: a fully human anti-CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies.
Kuhne MR; Mulvey T; Belanger B; Chen S; Pan C; Chong C; Cao F; Niekro W; Kempe T; Henning KA; Cohen LJ; Korman AJ; Cardarelli PM
Clin Cancer Res; 2013 Jan; 19(2):357-66. PubMed ID: 23213054
[TBL] [Abstract][Full Text] [Related]
17. The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
Fanelli MF; Chinen LT; Begnami MD; Costa WL; Fregnami JH; Soares FA; Montagnini AL
Histopathology; 2012 Aug; 61(2):153-61. PubMed ID: 22582975
[TBL] [Abstract][Full Text] [Related]
18. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells.
Schabath H; Runz S; Joumaa S; Altevogt P
J Cell Sci; 2006 Jan; 119(Pt 2):314-25. PubMed ID: 16390867
[TBL] [Abstract][Full Text] [Related]
19. Cells susceptible to epithelial-mesenchymal transition are enriched in stem-like side population cells from prostate cancer.
Luo Y; Cui X; Zhao J; Han Y; Li M; Lin Y; Jiang Y; Lan L
Oncol Rep; 2014 Feb; 31(2):874-84. PubMed ID: 24316717
[TBL] [Abstract][Full Text] [Related]
20. A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target.
Schulte A; Günther HS; Phillips HS; Kemming D; Martens T; Kharbanda S; Soriano RH; Modrusan Z; Zapf S; Westphal M; Lamszus K
Glia; 2011 Apr; 59(4):590-602. PubMed ID: 21294158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
